ストックスクリーナーアプリを入手
10.16
0.20%
0.02
前日終値:
$10.14
開ける：
$10.16
24時間の取引高:
277
Relative Volume:
0.00
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.20%
1か月 パフォーマンス:
+0.49%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$10.16
$10.16
1週間の範囲:
$10.13
$10.16
52週間の値動き範囲:
$10.00
$10.82
Drugs Made In America Acquisition Corp Stock (DMAAU) Company Profile
名前
Drugs Made In America Acquisition Corp
セクター
電話
954-870-3104
住所
2 PELICAN DR., FORT LAUDERDALE
DMAAU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DMAAU
Drugs Made In America Acquisition Corp
|
10.16 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.53 | 1.80B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.22 | 697.50M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.67 | 460.58M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.27 | 452.93M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.09 | 450.63M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp (DMAAU) 最新ニュース
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Q1 2025 SPAC Market Update & Outlook - Business Wire
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Pfizer Inc. - Britannica
AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica
Theratechnologies’ stock soars on disclosure of acquisition offer by U.S. company - Montreal Gazette
'I bought their dream': How a US company's huge land deal in Senegal went bust - Yahoo
Drugs Made In America Acquisition Corp. (DMAA) reports earnings - qz.com
Bright Green Unveils Massive $2B Cannabis Strategy with Zero Shareholder Dilution - StockTitan
Bright Green Corporation Announces the next steps for the completion of its restructuring plan - The Manila Times
DRUGS MADE IN AMERICA ACQUISITION CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
India-based Syngene acquires its first US biologics site - Manufacturing Dive
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger - Reuters
7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money
Q1 Earnings Estimate for WSP Global Issued By Raymond James - Defense World
Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World
adidas AG (OTCMKTS:ADDYY) Sees Large Growth in Short Interest - Defense World
ACS, Actividades de Construcción y Servicios, S.A. (OTCMKTS:ACSAY) Short Interest Up 104.9% in February - Defense World
Acorn Energy, Inc. (OTCMKTS:ACFN) Sees Large Increase in Short Interest - Defense World
Smithfield Foods, Inc’s (NASDAQ:SFD) Quiet Period Set To Expire on March 10th - Defense World
Short Interest in ANA Holdings Inc. (OTCMKTS:ALNPY) Decreases By 33.3% - Defense World
Alfa S.A.B. de C.V. (OTCMKTS:ALFFF) Short Interest Up 79.6% in February - Defense World
AIA Group Limited (OTCMKTS:AAGIY) Short Interest Update - Defense World
Aker ASA (OTCMKTS:AKAAF) Short Interest Up 61.0% in February - Defense World
Athena Gold Co. (OTCMKTS:AHNR) Sees Significant Growth in Short Interest - Defense World
Short Interest in Agricultural Bank of China Limited (OTCMKTS:ACGBF) Increases By 74.0% - Defense World
Short Interest in Alaris Equity Partners Income Trust (OTCMKTS:ADLRF) Grows By 137.9% - Defense World
AddLife AB (publ) (OTCMKTS:ADDLF) Short Interest Update - Defense World
Financial Comparison: Thomasville Bancshares (OTCMKTS:THVB) & U.S. Bancorp (NYSE:USB) - Defense World
OSI Systems (NASDAQ:OSIS) vs. Applied Optoelectronics (NASDAQ:AAOI) Critical Contrast - Defense World
Endava plc (NYSE:DAVA) Receives $39.10 Consensus Target Price from Brokerages - Defense World
Sanctuary Advisors LLC Has $782,000 Stake in Vornado Realty Trust (NYSE:VNO) - Defense World
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines - Business Wire
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion | Eli Lilly and Company - Eli Lilly and Company
A little-known Chinese company made a drug that beat the world’s biggest-selling medicine - CNN
BGXXBright Green Corp Latest Stock News & Market Updates - StockTitan
Drugs Made in America Acquisition Corp. Announces Advisory Team - The Manila Times
CanadaHelps Estimates $266 Million Loss for Charities Due to Canada Post Strike; Urges Canadians to Use Extended Donation Deadline to Give - The Manila Times
Drugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business Acquisitions - Nasdaq
Can This Power Team of Healthcare Veterans Reshape American Drug Manufacturing? - StockTitan
Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025 - The Manila Times
Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025 - Marketscreener.com
SPAC Alert: Key Trading Change Coming for Drugs Made In America UnitsWhat Investors Should Track - StockTitan
Drugs Made In America Acquisition Corp. Announces Trading Options for Public Offering Units Starting February 25, 2025 - Nasdaq
Mink Ventures Completes Acquisition of Warren Ni, Cu, Co Patents - The Manila Times
Drugs Made In America Acquisition Announces Closing Of Full Exercise Of IPO Over-Allotment Option - Marketscreener.com
ForexTV | Small Business Resources - ForexTV.com
Drugs Made In America Acquisition Corp. Secures Additional $30 Million in IPO as Underwriter Fully Exercises Overallotment Option - Nasdaq
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO ... - The Bakersfield Californian
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - TradingView
Nortech Systems (NASDAQ:NSYS) Coverage Initiated by Analysts at StockNews.com - Defense World
Drugs Made In America Acquisition Corp (DMAAU) 財務データ
Drugs Made In America Acquisition Corp (DMAAU) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.45%
0.10%
大文字化:
|
ボリューム (24 時間):